KMT2D and Miyoshi myopathy: Despite the distinct burden of subclonal mutations, some CH mutations were conservative among MM, AL, POEMS, and MGUS, including lymphoid and myeloid CH mutations, such as those in KMT2D, FAT1, MGA, and SYNE1, and myeloma driver genes like ZFHX3 and DIS3.